| Target and Pathway |
Top |
| Target(s) |
BDNF/NT-3 growth factors receptor (TrkB) |
Target Info
|
Inhibitor |
[1] |
| Fibroblast growth factor receptor 1 (FGFR1) |
Target Info
|
Inhibitor |
[1] |
| Fibroblast growth factor receptor 2 (FGFR2) |
Target Info
|
Inhibitor |
[1] |
| Fibroblast growth factor receptor 3 (FGFR3) |
Target Info
|
Inhibitor |
[1] |
| Fms-like tyrosine kinase 3 (FLT-3) |
Target Info
|
Inhibitor |
[1] |
| Macrophage-stimulating protein receptor (RON) |
Target Info
|
Inhibitor |
[1] |
| NT-3 growth factor receptor (TrkC) |
Target Info
|
Inhibitor |
[1] |
| Platelet-derived growth factor receptor beta (PDGFRB) |
Target Info
|
Inhibitor |
[1] |
| Proto-oncogene c-Met (MET) |
Target Info
|
Inhibitor |
[1] |
| Tyrosine-protein kinase Mer (MERTK) |
Target Info
|
Inhibitor |
[1] |
| Vascular endothelial growth factor receptor 2 (KDR) |
Target Info
|
Inhibitor |
[1] |
| Vascular endothelial growth factor receptor 3 (FLT-4) |
Target Info
|
Inhibitor |
[1] |
| VEGFR1 messenger RNA (VEGFR1 mRNA) |
Target Info
|
Inhibitor |
[1] |
|
KEGG Pathway
|
Ras signaling pathway
|
|
Rap1 signaling pathway
|
|
Cytokine-cytokine receptor interaction
|
|
PI3K-Akt signaling pathway
|
|
Focal adhesion
|
|
Hematopoietic cell lineage
|
|
Pathways in cancer
|
|
Transcriptional misregulation in cancer
|
|
Acute myeloid leukemia
|
|
Central carbon metabolism in cancer
|
|
Endocytosis
|
|
Axon guidance
|
|
Adherens junction
|
|
Bacterial invasion of epithelial cells
|
|
Epithelial cell signaling in Helicobacter pylori infection
|
|
Malaria
|
|
Proteoglycans in cancer
|
|
MicroRNAs in cancer
|
|
Renal cell carcinoma
|
|
Melanoma
|
|
MAPK signaling pathway
|
|
Signaling pathways regulating pluripotency of stem cells
|
|
Regulation of actin cytoskeleton
|
|
Prostate cancer
|
|
Calcium signaling pathway
|
|
Gap junction
|
|
HTLV-I infection
|
|
Glioma
|
|
Choline metabolism in cancer
|
|
VEGF signaling pathway
|
|
HIF-1 signaling pathway
|
|
Rheumatoid arthritis
|
|
Bladder cancer
|
|
Neurotrophin signaling pathway
|
|
Alcoholism
|
|
NetPath Pathway
|
TNFalpha Signaling Pathway
|
|
TSH Signaling Pathway
|
|
TCR Signaling Pathway
|
|
IL2 Signaling Pathway
|
|
IL1 Signaling Pathway
|
|
Panther Pathway
|
Angiogenesis
|
|
FGF signaling pathway
|
|
PDGF signaling pathway
|
|
VEGF signaling pathway
|
|
Pathway Interaction Database
|
VEGF and VEGFR signaling network
|
|
VEGFR3 signaling in lymphatic endothelium
|
|
Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)
|
|
Arf6 signaling events
|
|
Signaling events mediated by TCPTP
|
|
Posttranslational regulation of adherens junction stability and dissassembly
|
|
Direct p53 effectors
|
|
Syndecan-1-mediated signaling events
|
|
Stabilization and expansion of the E-cadherin adherens junction
|
|
a6b1 and a6b4 Integrin signaling
|
|
FGF signaling pathway
|
|
Regulation of retinoblastoma protein
|
|
Glypican 1 network
|
|
Syndecan-4-mediated signaling events
|
|
N-cadherin signaling events
|
|
Signaling events mediated by PTP1B
|
|
Beta3 integrin cell surface interactions
|
|
S1P3 pathway
|
|
Nectin adhesion pathway
|
|
SHP2 signaling
|
|
S1P1 pathway
|
|
Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling
|
|
PDGFR-beta signaling pathway
|
|
Validated targets of C-MYC transcriptional repression
|
|
PDGF receptor signaling network
|
|
HIF-2-alpha transcription factor network
|
|
Integrins in angiogenesis
|
|
Signaling events mediated by VEGFR1 and VEGFR2
|
|
Notch-mediated HES/HEY network
|
|
VEGFR1 specific signals
|
|
Neurotrophic factor-mediated Trk receptor signaling
|
|
amb2 Integrin signaling
|
|
Reactome
|
VEGF binds to VEGFR leading to receptor dimerization
|
|
Cell surface interactions at the vascular wall
|
|
Sema4D mediated inhibition of cell attachment and migration
|
|
PIP3 activates AKT signaling
|
|
Constitutive Signaling by Aberrant PI3K in Cancer
|
|
RAF/MAP kinase cascade
|
|
Neurophilin interactions with VEGF and VEGFR
|
|
Integrin cell surface interactions
|
|
EPHA-mediated growth cone collapse
|
|
VEGFA-VEGFR2 Pathway
|
|
VEGFR2 mediated cell proliferation
|
|
FGFR3 mutant receptor activation
|
|
ARMS-mediated activation
|
|
NGF-independant TRKA activation
|
|
PI3K/AKT activation
|
|
Activated point mutants of FGFR2
|
|
WikiPathways
|
Signaling by VEGF
|
|
Cell surface interactions at the vascular wall
|
|
TGF beta Signaling Pathway
|
|
Signaling of Hepatocyte Growth Factor Receptor
|
|
Focal Adhesion
|
|
Extracellular vesicle-mediated signaling in recipient cells
|
|
Signaling Pathways in Glioblastoma
|
|
miR-targeted genes in squamous cell - TarBase
|
|
miR-targeted genes in muscle cell - TarBase
|
|
miR-targeted genes in lymphocytes - TarBase
|
|
miR-targeted genes in epithelium - TarBase
|
|
Semaphorin interactions
|
|
Regulation of Actin Cytoskeleton
|
|
Endochondral Ossification
|
|
MAPK Signaling Pathway
|
|
Mesodermal Commitment Pathway
|
|
Hair Follicle Development: Induction (Part 1 of 3)
|
|
Integrated Pancreatic Cancer Pathway
|
|
Neural Crest Differentiation
|
|
Signaling by FGFR
|
|
Osteoblast Signaling
|
|
PIP3 activates AKT signaling
|
|
PDGF Pathway
|
|
Signaling by PDGF
|
|
Nifedipine Activity
|
|
Cardiac Progenitor Differentiation
|
|
Angiogenesis
|
|
Bladder Cancer
|
|
BDNF signaling pathway
|
|
NGF signalling via TRKA from the plasma membrane
|
|
SIDS Susceptibility Pathways
|
|
Ectoderm Differentiation
|
|
Hair Follicle Development: Organogenesis (Part 2 of 3)
|
|
Cardiac Hypertrophic Response
|
|
MicroRNAs in cardiomyocyte hypertrophy
|
